Get started
Author

Simon Newsome

Observed names: Newsome, S, Newsome, Simon, S Newsome, S. Newsome, S.J. Newsome, Simon J Newsome, Simon J. Newsome
Observed institutions: University of East Anglia, Universitat Autònoma de Barcelona, Novartis (Switzerland), Guy's Hospital, The Royal Melbourne Hospital, St Thomas' Hospital, King's College London, Guy's and St Thomas' NHS Foundation Trust, Ealing Hospital, Royal Brompton & Harefield NHS Foundation Trust, Peter MacCallum Cancer Centre, Harefield Hospital, UNSW Sydney, University of Chicago, St Vincent's Hospital Sydney, London School of Hygiene & Tropical Medicine, Royal Brompton Hospital, NIHR Royal Brompton Cardiovascular Biomedical Research Unit, St. Vincent's University Hospital, Novartis (United States), National Heart Centre Singapore, Ealing Hospital NHS Trust, Imperial College London, University of Edinburgh
ORCID: 0000-0002-1067-1217
Observed ORCID: 0000-0002-1067-1217
OpenAlex ID: A5002394921
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
2018 · Brian P Halliday, Rebecca Wassall, et al. · The Lancet · 658
PDF
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
2021 · Michael R. Bishop, Michael Dickinson, et al. · New England Journal of Medicine · 542
PDF
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
2017 · Brian P. Halliday, Ankur Gulati, et al. · Circulation · 385
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
2018 · Brian P. Halliday, A. John Baksi, et al. · JACC. Cardiovascular imaging · 334
PDF
Sex- and Age-Based Differences in the Natural History and Outcome of Dilated Cardiomyopathy
2018 · Brian P. Halliday, Ankur Gulati, et al. · European Journal of Heart Failure · 143
PDF
Phenotype and Clinical Outcomes of Titin Cardiomyopathy
2017 · Upasana Tayal, Simon Newsome, et al. · Journal of the American College of Cardiology · 134
PDF
Data Resource Profile: The UK Cystic Fibrosis Registry
2017 · David Taylor-Robinson, Olia Archangelidi, et al. · International Journal of Epidemiology · 90
PDF
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
2022 · Upasana Tayal, Job A.J. Verdonschot, et al. · Journal of the American College of Cardiology · 82
PDF
Microvascular Dysfunction in Dilated Cardiomyopathy
2019 · Ankur Gulati, Tevfik F. Ismail, et al. · JACC. Cardiovascular imaging · 80
Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
2017 · Upasana Tayal, Simon Newsome, et al. · Journal of the American College of Cardiology · 75
PDF
Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure
2018 · Ankur Gulati, Alan G. Japp, et al. · Circulation Cardiovascular Imaging · 61
PDF
Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score
2017 · Stuart J Pocock, Yong Huo, et al. · European Heart Journal Acute Cardiovascular Care · 45
PDF
External Aortic Root Support to Prevent Aortic Dilatation in Patients With Marfan Syndrome
2018 · Cemil Izgi, Simon Newsome, et al. · Journal of the American College of Cardiology · 44
Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry
2018 · Uwe Zeymer, Lieven Annemans, et al. · European Heart Journal Acute Cardiovascular Care · 44
Predictors of Left Ventricular Remodelling in Patients with Dilated Cardiomyopathy – A Cardiovascular Magnetic Resonance Study
2020 · Upasana Tayal, Ricardo Wage, et al. · European Journal of Heart Failure · 42
PDF
Estimating long‐term treatment effects in observational data: A comparison of the performance of different methods under real‐world uncertainty
2018 · Simon J. Newsome, Ruth H. Keogh, et al. · Statistics in Medicine · 35
PDF
Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation
2021 · Claire E. Raphael, Frances Mitchell, et al. · Journal of Cardiovascular Magnetic Resonance · 34
PDF
Predictors and Mechanisms of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
2020 · Claire E Raphael, Alphonsus C Liew, et al. · The American Journal of Cardiology · 25
PDF
Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-Fraction
2021 · Amrit S. Lota, Adam Tsao, et al. · JACC. Cardiovascular imaging · 22
PDF
Investigating the effects of long-term dornase alfa use on lung function using registry data
2018 · S.J. Newsome, R.M. Daniel, et al. · Journal of Cystic Fibrosis · 19
PDF
Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis
2021 · Simon J Newsome, Rhian M Daniel, et al. · American Journal of Epidemiology · 18
PDF
Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance
2017 · Vassilios S. Vassiliou, Paul D. Flynn, et al. · PLoS ONE · 17
PDF
Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis
2018 · Brodie L. Loudon, Eleana Ntatsaki, et al. · Scientific Reports · 13
PDF
43 Euroscore II and STS Risk Model Scores in Aortic Stenosis: Can We Rely on Them?
2016 · Nikhil Aggarwal, Subothini Selvendran, et al. · Heart View · 8
PDF
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
2024 · Evgeny Degtyarev, Natacha Bolaños, et al. · Future Oncology · 5
Works count: 61
Citation count: 2,974
H-index: 19
I10-index: 23
Year
Topic
Type